These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8077383)

  • 1. Expression of luteinizing hormone releasing hormone and its mRNA in human endometrial cancer cell lines.
    Irmer G; Bürger C; Ortmann O; Schulz KD; Emons G
    J Clin Endocrinol Metab; 1994 Sep; 79(3):916-9. PubMed ID: 8077383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High affinity binding and direct antiproliferative effects of luteinizing hormone-releasing hormone analogs in human endometrial cancer cell lines.
    Emons G; Schröder B; Ortmann O; Westphalen S; Schulz KD; Schally AV
    J Clin Endocrinol Metab; 1993 Dec; 77(6):1458-64. PubMed ID: 8263128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the messenger RNAs for luteinizing hormone-releasing hormone (LHRH) and its receptor in human ovarian epithelial carcinoma.
    Irmer G; Bürger C; Müller R; Ortmann O; Peter U; Kakar SS; Neill JD; Schulz KD; Emons G
    Cancer Res; 1995 Feb; 55(4):817-22. PubMed ID: 7850795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiproliferative signaling of luteinizing hormone-releasing hormone in human endometrial and ovarian cancer cells through G protein alpha(I)-mediated activation of phosphotyrosine phosphatase.
    Gründker C; Völker P; Emons G
    Endocrinology; 2001 Jun; 142(6):2369-80. PubMed ID: 11356684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Luteinizing hormone-releasing hormone agonist triptorelin and antagonist cetrorelix inhibit EGF-induced c-fos expression in human gynecological cancers.
    Gründker C; Völker P; Schulz KD; Emons G
    Gynecol Oncol; 2000 Aug; 78(2):194-202. PubMed ID: 10926802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective treatment of experimental human endometrial cancers with targeted cytotoxic luteinizing hormone-releasing hormone analogues AN-152 and AN-207.
    Engel JB; Keller G; Schally AV; Nagy A; Chism DD; Halmos G
    Fertil Steril; 2005 Apr; 83 Suppl 1():1125-33. PubMed ID: 15831285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential inhibitory effects on human endometrial carcinoma cell growth of luteinizing hormone-releasing hormone analogues.
    Borri P; Coronnello M; Noci I; Pesciullesi A; Peri A; Caligiani R; Maggi M; Torricelli F; Scarselli G; Chieffi O; Mazzei T; Mini E
    Gynecol Oncol; 1998 Dec; 71(3):396-403. PubMed ID: 9887238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression of gonadotropin-releasing hormone and its receptor in endometrial cancer, and its relevance as an autocrine growth factor.
    Chatzaki E; Bax CM; Eidne KA; Anderson L; Grudzinskas JG; Gallagher CJ
    Cancer Res; 1996 May; 56(9):2059-65. PubMed ID: 8616851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Internalization of cytotoxic analog AN-152 of luteinizing hormone-releasing hormone induces apoptosis in human endometrial and ovarian cancer cell lines independent of multidrug resistance-1 (MDR-1) system.
    Günthert AR; Gründker C; Bongertz T; Schlott T; Nagy A; Schally AV; Emons G
    Am J Obstet Gynecol; 2004 Oct; 191(4):1164-72. PubMed ID: 15507937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of luteinizing hormone-releasing hormone mRNA in the human prostatic cancer cell line LNCaP.
    Limonta P; Dondi D; Moretti RM; Fermo D; Garattini E; Motta M
    J Clin Endocrinol Metab; 1993 Mar; 76(3):797-800. PubMed ID: 8445038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Construction and expression of recombinant cecropin B-binding site of luteinizing hormone releasing hormone gene and its anticancer function].
    Li XY; Li HL; Zheng GY
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jul; 42(7):477-81. PubMed ID: 17961339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence of gonadotropin-releasing hormone receptor and its messenger ribonucleic acid in endometrial carcinoma and endometrium.
    Imai A; Ohno T; Iida K; Fuseya T; Furui T; Tamaya T
    Gynecol Oncol; 1994 Oct; 55(1):144-8. PubMed ID: 7959256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of type II luteinizing hormone-releasing hormone (LHRH-II) gene expression by the processed peptide of LHRH-I, LHRH-(1-5) in endometrial cells.
    Baldwin EL; Wegorzewska IN; Flora M; Wu TJ
    Exp Biol Med (Maywood); 2007 Jan; 232(1):146-55. PubMed ID: 17202595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GnRH agonist inhibits human telomerase reverse transcriptase mRNA expression in endometrial cancer cells.
    Nagai N; Oshita T; Mukai K; Shiroyama Y; Shigemasa K; Ohama K
    Int J Mol Med; 2002 Nov; 10(5):593-7. PubMed ID: 12373298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Jurkat cell proliferative activity is increased by luteinizing hormone-releasing hormone.
    Azad N; LaPaglia N; Kirsteins L; Uddin S; Steiner J; Williams DW; Lawrence AM; Emanuele NV
    J Endocrinol; 1997 May; 153(2):241-9. PubMed ID: 9166113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Luteinizing hormone-releasing hormone (LHRH) inhibits apoptosis induced by cytotoxic agent and UV-light but not apoptosis mediated through CD95 in human ovarian and endometrial cancer cells.
    Günthert AR; Gründker C; Böttcher B; Emons G
    Anticancer Res; 2004; 24(3a):1727-32. PubMed ID: 15274347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoactivation enhances the concentration of luteinizing hormone-releasing hormone peptide and its gene expression in human peripheral T-lymphocytes.
    Azad N; La Paglia N; Jurgens KA; Kirsteins L; Emanuele NV; Kelley MR; Lawrence AM; Mohagheghpour N
    Endocrinology; 1993 Jul; 133(1):215-23. PubMed ID: 8319570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of receptors for luteinizing hormone-releasing hormone in human ovarian and endometrial cancers: frequency, autoregulation, and correlation with direct antiproliferative activity of luteinizing hormone-releasing hormone analogues.
    Völker P; Gründker C; Schmidt O; Schulz KD; Emons G
    Am J Obstet Gynecol; 2002 Feb; 186(2):171-9. PubMed ID: 11854630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presence of luteinizing hormone-releasing hormone (LHRH) mRNA in rat spleen lymphocytes.
    Azad N; Emanuele NV; Halloran MM; Tentler J; Kelley MR
    Endocrinology; 1991 Mar; 128(3):1679-81. PubMed ID: 1999181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor mediated antiproliferative effects of the cytotoxic LHRH agonist AN-152 in human ovarian and endometrial cancer cell lines.
    Westphalen S; Kotulla G; Kaiser F; Krauss W; Werning G; Elsasser HP; Nagy A; Schulz KD; Grundker C; Schally AV; Emons G
    Int J Oncol; 2000 Nov; 17(5):1063-9. PubMed ID: 11029513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.